BUTALBITAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Butalbital, and what generic alternatives are available?
Butalbital is a drug marketed by Dr Reddys Labs Sa, Granules, Alvogen, Anda Repository, Halsey, Lgm Pharma, Ne Rx Pharma, Pharmobedient, Quagen, Senores Pharms, Watson Labs, Aurolife Pharma Llc, Gilbert Labs, Graham Dm, Hikma, Ingenus Pharms Llc, Key Therap, Lannett Co Inc, Mallinckrodt, Nuvo Pharms Inc, Taro, Genus, Abhai Llc, Able, Actavis Labs Ut Inc, Hikma Pharms, Mikart, Mirror Pharms Llc, Nesher Pharms, Specgx Llc, Strides Pharma, Strides Pharma Intl, Sun Pharm Industries, Vintage Pharms, Hikma Intl Pharms, Mpp Pharma, Actavis Elizabeth, Fosun Pharma, Ivax Pharms, Puracap Pharm, Quantum Pharmics, Novitium Pharma, and Stevens J. and is included in eighty-one NDAs.
The generic ingredient in BUTALBITAL is aspirin; butalbital; caffeine; codeine phosphate. There are twenty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aspirin; butalbital; caffeine; codeine phosphate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BUTALBITAL?
- What are the global sales for BUTALBITAL?
- What is Average Wholesale Price for BUTALBITAL?
Summary for BUTALBITAL
| US Patents: | 0 |
| Applicants: | 43 |
| NDAs: | 81 |
| DailyMed Link: | BUTALBITAL at DailyMed |
US Patents and Regulatory Information for BUTALBITAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mpp Pharma | BUTALBITAL, ASPIRIN AND CAFFEINE | aspirin; butalbital; caffeine | CAPSULE;ORAL | 078149-001 | Jun 13, 2007 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Able | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | TABLET;ORAL | 040390-001 | Jul 23, 2001 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mallinckrodt | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | CAPSULE;ORAL | 088758-001 | Mar 27, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
